• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的临床前模型

Preclinical models of Parkinson's disease.

作者信息

Bankiewicz K S, Sanchez-Pernaute R, Oiwa Y, Kohutnicka M, Cummins A, Eberling J

机构信息

National Institute of Neurological Disorders and Stroke (NIH), Bethesda, Maryland, USA.

出版信息

Curr Protoc Neurosci. 2001 May;Chapter 9:Unit9.4. doi: 10.1002/0471142301.ns0904s09.

DOI:10.1002/0471142301.ns0904s09
PMID:18428552
Abstract

Parkinson's disease is a neurodegenerative disease in which pigmented midbrain neurons progressively die producing a dopamine (DA) deficit in the striatum which manifests as an akinetic movement disorder. Experimentally induced striatal DA depletion in animals is a valid model of parkinsonism. The capacity of certain substances to damage catecholaminergic neurones has been used for a long time to produce DA deficiency in animals. This unit focuses on methods for inducing parkinsonism using the neurotoxins MPTP and 6-hydroxy dopamine and methods for evaluating the animals. Other models are briefly reviewed.

摘要

帕金森病是一种神经退行性疾病,其中脑黑质色素神经元逐渐死亡,导致纹状体中多巴胺(DA)缺乏,表现为运动不能性运动障碍。实验诱导动物纹状体DA耗竭是帕金森病的有效模型。某些物质损害儿茶酚胺能神经元的能力长期以来一直被用于在动物中产生DA缺乏。本单元重点介绍使用神经毒素MPTP和6-羟基多巴胺诱导帕金森病的方法以及评估动物的方法。其他模型将简要回顾。

相似文献

1
Preclinical models of Parkinson's disease.帕金森病的临床前模型
Curr Protoc Neurosci. 2001 May;Chapter 9:Unit9.4. doi: 10.1002/0471142301.ns0904s09.
2
Preclinical models of Parkinson's disease.帕金森病的临床前模型
Curr Protoc Toxicol. 2004 Feb;Chapter 1:Unit1.8. doi: 10.1002/0471140856.tx0108s18.
3
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.1-甲基-4-苯基-1,2,3,6-四氢吡啶在动物体内作为帕金森病模型的作用。
J Neural Transm Suppl. 1986;20:11-39.
4
Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.游泳测试作为帕金森病MPTP模型中运动障碍的一项指标:两种小鼠品系的比较研究
Behav Brain Res. 2005 Sep 8;163(2):159-67. doi: 10.1016/j.bbr.2005.04.011.
5
Neuroprotection in Parkinson models varies with toxin administration protocol.帕金森病模型中的神经保护作用因毒素给药方案而异。
Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x.
6
Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.在联合给予1-甲基-4-苯基-1,2,3,6-四氢吡啶和二乙基二硫代氨基甲酸盐诱导的帕金森病小鼠模型中运动功能和多巴胺能参数的恢复
J Neural Transm (Vienna). 2003 Aug;110(8):871-83. doi: 10.1007/s00702-003-0002-1.
7
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.帕金森病中内源性类吗啡化合物免疫反应性增加。
Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.
8
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.帕金森病症状前期和症状期MPTP处理小鼠黑质纹状体多巴胺能神经元中酪氨酸羟化酶的表达与活性
J Neurol Sci. 2014 May 15;340(1-2):198-207. doi: 10.1016/j.jns.2014.03.028. Epub 2014 Mar 21.
9
Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease.δ阿片受体激动剂在帕金森病啮齿动物和灵长类动物模型中的抗帕金森病作用。
Exp Neurol. 2001 Nov;172(1):189-98. doi: 10.1006/exnr.2001.7763.
10
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.小分子TrkB激动剂脱氧格杜宁可保护啮齿动物黑质纹状体多巴胺能神经元免受6-羟基多巴胺和MPTP诱导的神经毒性。
Neuropharmacology. 2015 Dec;99:448-58. doi: 10.1016/j.neuropharm.2015.08.016. Epub 2015 Aug 14.

引用本文的文献

1
Movement-related activity in the internal globus pallidus of the parkinsonian macaque.帕金森猕猴苍白球内侧部与运动相关的活动
J Neurophysiol. 2025 Aug 1;134(2):741-765. doi: 10.1152/jn.00611.2024. Epub 2025 Jul 22.
2
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.激活KEAP1/Nrf2信号通路的天然化合物作为治疗特发性帕金森病的潜在新药
Antioxidants (Basel). 2024 Sep 18;13(9):1125. doi: 10.3390/antiox13091125.
3
Movement-related activity in the internal globus pallidus of the parkinsonian macaque.
帕金森猕猴苍白球内侧部与运动相关的活动
bioRxiv. 2024 Aug 30:2024.08.29.610310. doi: 10.1101/2024.08.29.610310.
4
Detecting rhythmic spiking through the power spectra of point process model residuals.通过点过程模型残差的功率谱检测节律性尖峰。
J Neural Eng. 2024 Aug 5;21(4):046041. doi: 10.1088/1741-2552/ad6188.
5
Detecting rhythmic spiking through the power spectra of point process model residuals.通过点过程模型残差的功率谱检测节律性尖峰。
bioRxiv. 2024 Mar 25:2023.09.08.556120. doi: 10.1101/2023.09.08.556120.
6
Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress.高效、选择性和竞争性的基于吲哚的单胺氧化酶B抑制剂可保护PC12细胞免受6-羟基多巴胺和鱼藤酮诱导的氧化应激。
Antioxidants (Basel). 2021 Oct 19;10(10):1641. doi: 10.3390/antiox10101641.
7
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress.褪黑素类似物可有效抑制单胺氧化酶B并保护PC12细胞免受氧化应激。
Antioxidants (Basel). 2021 Oct 12;10(10):1604. doi: 10.3390/antiox10101604.
8
The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.帕金森病的BSSG大鼠模型:向有效、可预测的疾病模型迈进。
EPMA J. 2017 Sep 4;8(3):261-271. doi: 10.1007/s13167-017-0114-6. eCollection 2017 Sep.
9
Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.帕金森病猴的初级运动皮层:主动运动编码改变
Brain. 2016 Jan;139(Pt 1):127-43. doi: 10.1093/brain/awv312. Epub 2015 Oct 21.
10
Cell viability and dopamine secretion of 6-hydroxydopamine-treated PC12 cells co-cultured with bone marrow-derived mesenchymal stem cells.骨髓间充质干细胞共培养对 6-羟多巴胺处理的 PC12 细胞活力和多巴胺分泌的影响。
Neural Regen Res. 2012 May 15;7(14):1101-5. doi: 10.3969/j.issn.1673-5374.2012.14.009.